World Congress on Immunotherapy & Infectious Diseases 2026

24th-25th September 2026 | Barcelona, Spain

Welcome to the World Congress on Immunotherapy & Infectious Diseases

World Congress on Immunotherapy & Infectious Diseases (WIIDC 2026) brings together global leaders in immunology, infectious disease research, and translational medicine to advance the science of immune-based therapies and pandemic resilience.

Set to take place from September 25–26, 2026 in Barcelona, Spain, WIIDC 2026 will explore cutting-edge developments in immune checkpoint inhibitors, cancer immunotherapy, vaccinology, monoclonal antibody therapies, host-pathogen interactions, emerging and re-emerging infections, immune system engineering, and global health strategies.

Researchers, clinicians, and industry innovators will gather to shape the future of infection control, immune modulation, and personalized immunotherapy — from bench to bedside to public health policy.

Key Features of Our Conference Include​

Engaging Keynote Speakers

WIIDC 2026 will host globally respected leaders in immunotherapy, infectious diseases, vaccine development, and global health who will deliver powerful keynote sessions that spotlight breakthroughs in clinical practice and translational immunology.

1

Oral and Poster Presentations

Scientific contributors will share cutting-edge research covering topics such as antimicrobial resistance, host-pathogen interactions, immunotherapeutics, novel vaccines, and emerging infectious threats. These sessions are designed to promote dialogue, visibility, and collaboration.

2

Panel Discussions

Interactive expert panels will address pressing issues such as pandemic preparedness, global access to immunotherapies, clinical trial design, and the integration of immunology in infectious disease management. Each panel encourages diverse insights from clinicians, scientists, policymakers, and industry leaders.

3

Workshops and Training Sessions

Participants will gain hands-on experience through focused workshops in immune profiling, infectious disease modeling, vaccine analytics, and computational immunology. These sessions are particularly valuable for clinicians and early-career researchers aiming to advance technical expertise.

4

Exhibitions and Innovation Showcase

Attendees will explore a curated showcase of diagnostics, vaccine platforms, monoclonal antibody therapies, and next-gen immunotherapeutic from leading biotech and pharmaceutical innovators shaping the future of infectious disease management.

5

Women’s Health Excellence Awards

To celebrate impactful contributions in immunotherapy and infectious disease research, WIIDC 2026 will present the Best Oral Presentation, Best Poster, Young Investigator Award, and Innovation in Infectious Disease Science Award.

6

By attending the World Congress on Immunotherapy & Infectious Diseases 2026, you can stay updated on the latest trends, discoveries, and breakthroughs in immune-based treatments and vaccinology, and contribute to developing next-generation solutions for global health threats. We look forward to welcoming you at our upcoming event!

Scientific Sessions

Focus Areas Include:

  • Innate vs. adaptive immunity
  • T-cell and B-cell responses
  • Cytokines, chemokines, and signaling pathways
  • Immunological memory and regulation
  • Immunopathology in infection and inflammation
  • Host genetic susceptibility to infectious agents

Focus Areas Include:

  • Immune checkpoint inhibitors (PD-1, CTLA-4, etc.)
  • CAR-T and cellular therapies
  • Monoclonal antibodies in infectious disease
  • Immune modulation in autoimmunity
  • Immunotherapies for viral/bacterial infections
  • Cytokine therapy and biologics

Focus Areas Include:

  • COVID-19, influenza, Nipah, Ebola
  • Zoonotic spillover and pandemic preparedness
  • Vector-borne and foodborne infections
  • Climate-driven disease emergence
  • Global disease surveillance and early warning systems
  •  

Focus Areas Include:

  • Bacterial, viral, fungal, and parasitic genomics
  • Resistance gene evolution and horizontal gene transfer
  • Pathogen sequencing in outbreak tracking
  • Mutation patterns, fitness cost, and virulence
  • Bioinformatics pipelines for microbial genomics

Focus Areas Include:

  • mRNA, vector-based, protein subunit vaccines
  • Universal flu and pan-pathogen vaccines
  • Vaccine adjuvants and delivery technologies
  • Maternal and pediatric immunization
  • Public trust, vaccine hesitancy, and education
  • Access and equity in LMICs
  •  

Focus Areas Include:

  • Mechanisms of resistance (β-lactamases, efflux pumps)
  • Multi-drug resistant (MDR) pathogens
  • Stewardship in clinical and agricultural settings
  • New antibiotic discovery and repurposing
  • Global surveillance initiatives (e.g., GLASS)
  • AMR in immunocompromised populations

Focus Areas Include:

  • Molecular and rapid diagnostics (PCR, LAMP, CRISPR-based)
  • Serology and antigen detection
  • Single-cell immune profiling (scRNA-seq, CyTOF)
  • Immune repertoire sequencing (TCR, BCR)
  • Integration of diagnostics in clinical workflows
  • Point-of-care testing for remote areas
  •  

Focus Areas Include:

  • Mechanisms of immune evasion
  • Mucosal immunity and epithelial barriers
  • Co-infections and immune crosstalk
  • Microbiome-immune system interactions
  • Systems biology of infection dynamics
  • Immunometabolism during infection
  •  

Focus Areas Include:

  • Vaccine and drug access in LMICs
  • Public health communication in crises
  • Telegenetics, eHealth, and mobile diagnostics
  • Pandemic response policy and preparedness
  • Disease burden modeling and implementation science
  • Global partnerships and funding strategies

Focus Areas Include:

  • Ethical frameworks for vaccine/testing deployment
  • Regulation of novel biologics and diagnostics
  • Environmental links to zoonotic disease
  • Antibiotic use in agriculture and One Health integration
  • Cross-sector surveillance (human–animal–environment)
  • Data privacy and consent in genomic epidemiology


Tentative Program

8:00 am - 9:00 am

Registration and Welcome Breakfast

9:00 am - 9:30 am

Inaugural Ceremony

9:30 am - 10:30 am

Keynote Session

10:30 am - 11:00 am

Networking Break

11:00 am - 12:00 pm

Panel Discussion

12:00 pm - 1:00 pm

Lunch Break

1:00 pm - 2:00 pm

Presentation

2:00 pm - 3:00 pm

Presentation

3:00 pm - 3:30 pm

Networking Break

4:30 pm - 5:00 pm

Presentation

5:30 pm - 6:30 pm

Networking Reception

8:30 am - 9:00 am

Morning Coffee and Networking

9:00 am - 10:00 am

Keynote Session

10:00 am - 11:00 am

Case Study Presentations

11:00 am - 11:30 am

Networking Break

11:30 am - 12:30 pm

Interactive Discussion

12:30 pm - 1:30 pm

Lunch Break

2:30 pm - 3:30 pm

Presentation

3:30 pm - 4:00 pm

Presentation

4:00 pm - 5:00 pm

Networking Break

5:00 pm - 6:00 pm

Panel Discussion

Target Audience

This congress is designed for professionals across disciplines who are dedicated to advancing women’s health, hormonal science, and reproductive care, including:

  • Gynecologists & Obstetricians
  • Reproductive Endocrinologists & Fertility Specialists
  • Endocrinologists & Hormone Researchers
  • Maternal-Fetal Medicine Experts
  • Nurses & Midwives
  • Women’s Health Physicians & General Practitioners
  • Oncologists (Gynecologic & Breast Cancer)
  • Adolescent & Menopause Care Providers
  • Mental Health Professionals & Psychologists
  • Public Health Experts & Health Policy Advocates
  • Biomedical Scientists & Researchers
  • Pharmaceutical & MedTech Industry Professionals
  • FemTech Innovators & Startups
  • Health Educators & Patient Advocates

Dates to Remember

Early Bird Abstract submission ends

Date: January 31, 2026

Early Bird Registration ends

Date: January 31, 2026

Mid-Term Registration ends on

Date: May 31, 2026

Final Registration
ends on

Date: August 31, 2026

Get in touch

Subscription Form
Scirator Conferences

Scirator Conferences

Typically replies within an hour

I will be back soon

Scirator Conferences
Hello... How can I help you?
Start Chat with:
chat